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Introduction
The endothelium plays a central role in pathophysiology
of sepsis. Systemic inflammation results in endothelial
dysfunction, contributing to the development of shock
and multiple organ dysfunction. However, an easy to
obtain, early, and clinically applicable marker of
endothelial dysfunction is currently not available. Such a
marker could guide early and targeted therapy such as
selective iNOS inhibition. Endocan is a soluble proteo-
glycan secreted by endothelial cells in response to pro-
inflammatory cytokines, bacterial endotoxins, and angio-
genic factors, and enhances microvascular permeability.
Plasma endocan levels are increased in septic patients,
and have been shown to correlate with sepsis severity
and mortality. However, the direct relationship between
endocan and endothelial function has not yet been
investigated in humans in vivo.
Objectives
To investigate the kinetics of plasma endocan levels dur-
ing human endotoxemia and to examine their relation
with inflammation-induced endothelial dysfunction.
Methods
Seventeen healthy male volunteers were subjected to
experimental endotoxemia (infusion of 2 ng/kg E.Coli
lipopolysaccharide [LPS]). Plasma levels of inflammatory
cytokines (TNF-a, IL-6, IL-10, and IL-1RA), endocan,
ICAM, and VCAM were measured at T = 0, 0.5, 1, 1.5,
2, 4, 6 and 8 hrs after LPS infusion. Both before and 4
hrs after LPS administration, endothelial function was
assessed by determination of the vasodilatory response
of forearm blood vessels to the incremental intra-arterial
infusion of endothelium-dependent (acetylcholine) or
endothelium-independent (nitroglycerine/nitroprusside)
vasodilators using venous occlusion plethysmography.
Furthermore, correlations between the increases in
plasma endocan, ICAM, and VCAM levels, and the
endotoxemia-induced changes in vasodilatory responses
were explored.
Results
Plasma levels of all measured cytokines, endocan, ICAM,
and VCAM concentrations significantly increased after
LPS administration (Figure 1). LPS administration
resulted in a significantly blunted response of forearm
vasculature to acetylcholine (P = 0.028, Figure 2A),
whereas the response to nitroglycerine/nitroprusside was
not significantly affected (P = 0.11, Figure 2B). Further-
more, there was a significant correlation between the
increase in plasma endocan levels and the attenuation of
vasodilatory responses to acetylcholine (Pearson’s r =
-0.49, P = 0.049). No correlation existed between plasma
levels of ICAM or VCAM and the attenuation of the
acetylcholine-induced vasodilatory response.
Conclusions
Endocan levels are related to endothelial dysfunction
during systemic inflammation in humans in vivo. There-
fore, it may prove to be a suitable marker for the early
identification of endothelial dysfunction and could guide
targeted therapy.
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Figure 1 Plasma concentrations of cytokines TNF-a and IL-6 (A), endocan (B), and ICAM and VCAM (C) during endotoxemia. Data in
panels A and C are expressed as mean with SEM, and analyzed using repeated measures one-way ANOVA (P-values apply to all indicated
parameters). The non-depicted anti-inflammatory cytokines IL-10 and IL-1RA peaked at T = 3 hrs (702 ± 183 pg/ml and 7332 ± 759 pg/ml,
respectively, both P < 0.0001). Data in panel B are expressed as median with interquartile range, and analzed using Friedman test.
Figure 2 Forearm blood flow (FBF) ratios in response to the acetylcholine (A) and nitroglyverine/nitroprusside (B) before and during
endotoxemia. FBF ratios were calculated by dividing the flow in the experimental arm by the concurrent flow in the non-infused (control) arm,
to adjust for systemic changes in flow. At baseline this ratio was set at 100%. Data are expressed as mean with SEM. p-values indicate difference
between FBF ratios before and after LPS administration calculated using repeated measures two-way ANOVA (interaction term).
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